Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
2009
Hepatic triacylglycerol accumulation and insulin resistance
2008
Gastric cancer
2016 Standout
Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units
2012
Gender Difference in Hepatic Steatosis Index and Lipid Accumulation Product Ability to Predict Incident Metabolic Syndrome in the Historical Cohort of the Brisighella Heart Study
2013
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
2010 Standout
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
2012
Alcohol consumption appears to protect against non-alcoholic fatty liver disease
2010
Burden of liver diseases in the world
2018 Standout
Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study
2013
Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital
2011
Light and Moderate Alcohol Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population
2009
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
The metabolic syndrome
2010 Standout
Lifestyle Modification for Metabolic Syndrome: A Systematic Review
2014
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
2016
Liver Fat Content, Evaluated through Semi-Quantitative Ultrasound Measurement, Is Associated with Impaired Glucose Profiles: A Community-Based Study in Chinese
2013
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
A position statement on NAFLD/NASH based on the EASL 2009 special conference
2010
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World
2015
Incidence and natural course of fatty liver in the general population: The Dionysos study
2007
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
2014
Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012
2014
Prevalence and Trends in Obesity Among US Adults, 1999-2008
2010 Standout
Diabetic nephropathy—What are the unmet needs?
2008
The medical complications of obesity
2006
Correlates and Heritability of Nonalcoholic Fatty Liver Disease in a Minority Cohort
2009
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
From NAFLD in clinical practice to answers from guidelines
2013
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Nonobese Fatty Liver Disease
2016
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
2020
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Trends in Outpatient Resource Utilizations and Outcomes for Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease
2014
Diabetes in Asia
2009 Standout
Psoriasis
2015 Standout
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
2013
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
2011
Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study
2013
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
2008
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
2022
Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?
2015
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
2013
Use of Insulin Sensitizers in NASH
2007
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
2007
Fatty liver incidence and predictive variables
2010
Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
2011
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
2011
Nutritional programming of the metabolic syndrome
2009
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
2019
Nonobese Population in A Developing Country Has A High Prevalence of Nonalcoholic Fatty Liver and Significant Liver Disease
2010
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
2017
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
2015
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
NAFLD in Asia—as common and important as in the West
2013
Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
2014
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
2010
Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
2014
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
2016
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
2006
Epigenetic modifications and human disease
2010 Standout
A simple index of lipid overaccumulation is a good marker of liver steatosis
2010
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
2012
Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study
2012
Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes
2006
Epidemiology and Natural History of NAFLD and NASH
2007
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
2009
Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases
2007
Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society
2012
PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease†,‡
2010
Inflammation in obesity, diabetes, and related disorders
2022 Standout
The Epidemiology of Obesity
2007
Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease
2010
Hepatocellular carcinoma
2022 Standout
Prevalence and risk factors for non‐alcoholic fatty liver disease among adults in an urban Sri Lankan population
2009
Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons
2009
Heritability of non‐alcoholic fatty liver disease and association with abnormal vascular parameters: A twin study
2012
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens
2010
Population-Based Prevention of Obesity
2008
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
2008
Trends in Obesity Among Adults in the United States, 2005 to 2014
2016 Standout
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
2013
De novolipogenesis in the liver in health and disease: more than just a shunting yard for glucose
2015
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study
2015
Guidelines for the Primary Prevention of Stroke
2014 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Is there an ‘ideal’ diet for patients with NAFLD?
2021
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
2009
Non‐alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups
2013
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
2017
Fatty Liver
2007
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
2007
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
2015
Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects
2014
The Metabolic Syndrome
2008 Standout
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
NAFLD and Chronic Kidney Disease
2016
The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non‐alcoholic fatty liver disease: A randomized controlled trial
2021
Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study
2021
Liver Fat in the Metabolic Syndrome
2007
Nonalcoholic Fatty Liver Disease
2015 Standout
Obesity-Associated Liver Disease
2008
Works of Junichi Okuda being referenced
Correlations of hemoglobin index (IHb) of gastric mucosa with Helicobacter pylori (H. pylori) infection and inflammation of gastric mucosa
2004
The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Reflects the Metabolic Syndrome and Visceral Fat Accumulation
2007
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
2005